Association of IFIS and vasodepressor medication.
El-Ghatit
Ali M
AM
D058668:Adrenergic alpha-1 Receptor Antagonists; D000317:Adrenergic alpha-Antagonists / Q000009:adverse effects*; D017292:Doxazosin / Q000009:adverse effects*; D006801:Humans; D006973:Hypertension / Q000188:drug therapy; D007431:Intraoperative Complications; D007499:Iris Diseases / Q000139:chemically induced* / Q000453:epidemiology; D018918:Phacoemulsification; D011680:Pupil / Q000187:drug effects*; D013577:Syndrome; D014665:Vasodilator Agents / Q000009:adverse effects*
D058668:Adrenergic alpha-1 Receptor Antagonists; D000317:Adrenergic alpha-Antagonists; D014665:Vasodilator Agents; D017292:Doxazosin